The genus Candida belongs to the fungal kingdom (Fungi), among which the species Candida albicans is clinically important, as it is responsible for systemic candidiasis worldwide. Due to its increasing resistance to currently available antifungal agents and its remarkable ability to survive in diverse environments, this yeast represents an ever-growing challenge in modern medicine. The severity of the problem has also been highlighted by the World Health Organization (WHO), which has classified C. albicans as a critical priority pathogen. This further underscores the urgent need for the development of novel and effective antifungal agents.
One of the key strategies in discovering new potential active compounds is the screening of compound libraries. As part of this master's thesis, a total of 1629 compounds from the compound library of the Faculty of Pharmacy, University of Ljubljana, were tested. These compounds had originally been synthesized or purchased for various research projects primarily focused on antitumor and antimicrobial activity, as well as on the development of specific enzyme inhibitors. In the initial screening, 12 compounds were identified as exhibiting inhibitory activity against C. albicans. Furthermore, the minimum inhibitory concentrations (MICs) of the potential compounds identified in the initial screening were determined using the microdilution method. Based on these results, 8 compounds were conclusively confirmed to exhibit clear inhibitory activity against C. albicans.
The majority of active compounds belonged to derivatives of pyrido[4,3-b]carbazoles, which are known for their antitumor activity and have been previously associated with antifungal effects against C. albicans. Compounds with a cyanothiophene core, a naphthamide core, and derivatives of 6-(trifluoromethyl) pyrimidin-2-amine also demonstrated significant potential for the development of new antifungal agents. The results of this thesis therefore provide an important basis for the further development of potential antifungal agents, including structure–activity relationship (SAR) analysis, elucidation of mechanisms of action, and optimization of physicochemical properties.
|